|
|
|
2005 Neurotech Leaders Forum
October 20-21, 2005
Preliminary Agenda
Day One: Neurotech Short Courses
This half-day event is targeted at early-stage neurotechnology firms and research professionals contemplating launching a neurotech start-up. In Track A, presenters will offer a detailed background on the basics of the neurotechnolgy and neuropharmacology industries. In Track B, conference faculty will offer tutorial courses in preparing a business plan, conducting market and competitive research, and locating sources of funding specific to the neurotechnology industry.
| 12:00-1:00 |
Registration, Peninsula Ballroom |
Track A-Technology |
| 1:00-2:30 |
Basics of Neurotechnology
Warren Grill, Ph.D, Senior Technical Editor, Neurotech
Reports
In this session, one of the nation's leading experts on neurotechnology, Warren Grill of Duke University, will present a tutorial on the fundamentals of neurostimulation, neuromodulation, deep-brain stimulation, and related topics. The tutorial will explain how neurotech devices work, and include a discussion of product features, stimulation parameters, targeted locations. |
| 2:30-3:00 |
Refreshment Break |
| 3:00-4:30 |
Neuropharmacology Industry Fundamentals
Zack Lynch, Managing Director, NeuroInsights
This session gives attendees an overview of the $87 billion neuropharmaceutical sector, including the cogniceutical, emoticeutical, and sensoceutical segments. It looks at several different modes of treatment, such as serotinin reuptake inhibitors and MAO inhibitors. The session also discusses potential areas of overlap bewteen neurotech devices and pharmaceuticals and opportunities for collaboration with neuropharma vendors. |
Track B-Finance |
| 1:00-2:30 |
Obtaining Venture Capital Financing
Glenn Cornett, Ph.D, M.D., Senior Financial Editor, Neurotech Reports
This session offers specific and practical advice on preparing a set of initial materials, including executive summary, investor presentation, and financial model, that will attract attention from venture capital firms. It includes examples of items that have made the difference between funding and no funding decisions. The presenter will also discuss how to find the most appropriate VC firm and how to arrange a meeting with the key person at the firm. |
| 2:30-3:00 |
Refreshment Break |
| 3:00-4:30 |
Neurotechnology Market Fundamentals
James Cavuoto, Editor and Publisher, Neurotech Reports
This session gives attendees an overview of the neurotechnology market, with discussion of overall size, market segments, growth rates, competition, and key players. It will also include discussion of the various markets for neurological diseases and disorders. |
| 4:30-5:00 |
Consultation Sessions
In these personalized sessions, participant will have an opportunity to meet with Neurotech Reports editors and conference faculty for individualized advice, guidance, and consultation.
|
| 5:00-7:00 |
Cocktail Reception
|
| |
|
Day Two: Neurotech Industry Sessions
This full-day conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are working to grow this new industry.
| 8:30-9:00 |
Registration and Coffee, Peninsula Ballroom |
| 9:00-9:15 |
Introduction |
| 9:15-9:45 |
Keynote Address: Launching a Neurotech Startup
Alan Levy, Ph.D., President and CEO, Northstar Neuroscience |
| 9:45-10:15 |
Neurotechnology Industry Update
James Cavuoto, Editor and Publisher, Neurotech Reports
This session will provide attendees with an up-to-date look at the neurotechnology industry, including discussion of deals, merger and acquisition activity, and venture capital funding that has occurred in the last year. |
| 10:15-10:30 |
Coffee Break
|
| 10:30-11:15 |
The Role of Government in Neurotechnology
Glenn Cornett, M.D., Ph.D., Senior Financial Editor, Neurotech Reports, Moderator
Joe Pancrazio, Ph.D, National Institutes of Health
Jeff Newman, California Technology and Commerce Agency
Gail Schechter, BioIntelligence
This session will examine the role that various government agencies can play in stimulating or inhibiting the growth of the neurotechnology industry. Topics covered include the approval process, reimbursement, oversight, legal issues, and funding opportunities.
|
| 11:15-12:00 |
Serving the User
James Cavuoto, Editor, Neurotech Reports, Moderator
Gary Karp, Author
Jennifer French, Society to Increase Mobility
This session will examine the key role that neurotechnology devices can play in improving the lives of individuals with a variety of neurological diseases and disorders. Panelists will offer their views on how products can be improved, new market opportunities, working with clinicians, and other factors that influence customer satisfaction. |
| 12:00-1:30 |
Luncheon |
| 1:30-3:00 |
Entrepreneur Panel
James Cavuoto, Editor, Neurotech Reports, Moderator
Mark Carney, CEO, Andara Life Science, Inc.
Elisabeth Hager, CEO, GentCorp.
K.C. Fadem, COO, Neuronetrix, Inc.
Souhile Assaf, CEO, Medtrode Inc.
Daryl Kipke, CEO, NeuroNexus Technologies
This session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
| 3:00-3:15 |
Refreshment Break |
| 3:15-4:00 |
New Technologies Panel
Warren Grill, Ph.D., Senior Technical Editor, Neurotech Reports, Moderator
John McDonald, M.D., Ph.D., Director, International Center for Spinal Cord Injury
Iain Glass, President and CEO, Mindcare Centres
This session looks at several new technology areas within the field of neurotechnology and explores the commercialization potential of each. Technologies covered include deep brain stimulation, brain-computer interfaces, magnetic stimulation systems, nanobiotechnology applications, and biomimetic microelectronics. |
| 4:00-5:00 |
Venture Capital Firms Perspective
James Cavuoto, Editor, Neurotech Reports, Moderator
Leslie Bottorff, Onset Ventures
Roger Quy, Technology Partners
Daniel O'Connell, NeuroVentures Capital
Alex Arrow, Lazard Capital Markets
In this wrap-up session, representatives from several key venture capital firms in the neurotechnology space will offer their feedback on the status of the industry and their impressions of the issues discussed during the day. |
| 5:00-7:00 |
Cocktail Reception |
| |
|
|
